sorafenib has been researched along with daurisoline in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (daurisoline) | Trials (daurisoline) | Recent Studies (post-2010) (daurisoline) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 35 | 0 | 9 |
| Protein | Taxonomy | sorafenib (IC50) | daurisoline (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 9.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Liu, GL; Mu, W; Zhang, JG; Zhang, X; Zhou, HM | 1 |
1 other study(ies) available for sorafenib and daurisoline
| Article | Year |
|---|---|
The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.
Topics: Animals; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Mice; Neovascularization, Pathologic; Sorafenib | 2021 |